Trials / Completed
CompletedNCT02549352
Efficacy and Safety of LEO 43204 in Field Treatment of Actinic Keratosis on Balding Scalp Including 12-month Follow-up
- Status
- Completed
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 391 (actual)
- Sponsor
- LEO Pharma · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The objective of the trial is to compare the short term efficacy of LEO 43204 gel with vehicle gel in AK on the balding scalp when applied topically once daily for 3 consecutive days as field treatment
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | LEO43204 gel | |
| DRUG | Vehicle gel |
Timeline
- Start date
- 2015-11-01
- Primary completion
- 2016-09-22
- Completion
- 2017-08-01
- First posted
- 2015-09-15
- Last updated
- 2025-03-13
- Results posted
- 2018-12-26
Locations
1 site across 1 country: Germany
Source: ClinicalTrials.gov record NCT02549352. Inclusion in this directory is not an endorsement.